Madrigal Pharmaceuticals (MDGL) Free Cash Flow (2019 - 2025)
Historic Free Cash Flow for Madrigal Pharmaceuticals (MDGL) over the last 14 years, with Q3 2025 value amounting to $79.0 million.
- Madrigal Pharmaceuticals' Free Cash Flow rose 21657.25% to $79.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$161.6 million, marking a year-over-year increase of 6269.96%. This contributed to the annual value of -$457.0 million for FY2024, which is 4031.97% down from last year.
- Latest data reveals that Madrigal Pharmaceuticals reported Free Cash Flow of $79.0 million as of Q3 2025, which was up 21657.25% from -$47.1 million recorded in Q2 2025.
- Madrigal Pharmaceuticals' 5-year Free Cash Flow high stood at $79.0 million for Q3 2025, and its period low was -$149.5 million during Q1 2024.
- In the last 5 years, Madrigal Pharmaceuticals' Free Cash Flow had a median value of -$59.1 million in 2022 and averaged -$65.7 million.
- In the last 5 years, Madrigal Pharmaceuticals' Free Cash Flow plummeted by 9321.24% in 2021 and then surged by 21657.25% in 2025.
- Over the past 5 years, Madrigal Pharmaceuticals' Free Cash Flow (Quarter) stood at -$48.2 million in 2021, then decreased by 21.55% to -$58.5 million in 2022, then plummeted by 38.3% to -$81.0 million in 2023, then dropped by 29.29% to -$104.7 million in 2024, then skyrocketed by 175.46% to $79.0 million in 2025.
- Its Free Cash Flow was $79.0 million in Q3 2025, compared to -$47.1 million in Q2 2025 and -$88.9 million in Q1 2025.